MANKIND PHARMA Q2 FY27 (CONS.) ; NET PROFIT UP 37.67% AT ₹716.12 CR (YOY), UP 24.74% (QOQ)

REVENUE UP 17.33% AT ₹4,337.86 CR (YOY), UP 7.62% (QOQ) EBITDA UP 27.13% AT ₹1,171.25 CR (YOY), UP 10.89% (QOQ) MARGINS AT 27.00% VS 24.92% (YOY), 26.20% (QOQ)

MANKIND PHARMA LIMITED

← Back to feed